• Je něco špatně v tomto záznamu ?

Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate

M Petrik, A Laznickova, M Laznicek, MR Zalutsky

. 2007 ; 27 (6B) : 3941-3946.

Jazyk angličtina Země Řecko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026704
E-zdroje Online

NLK Free Medical Journals od 2004 do Před 2 roky
Open Access Digital Library od 2004-01-01

BACKGROUND: Somatostatin analogues labelled with radiometals or radiohalogens are useful for the imaging and treatment of somatostatin receptor-containing tumours. In this study, the procedures for the radioiodination of glucose-Tyr3-octreotate (gluc-Tyr3-tate) and radiolabelling of DOTA-Tyr3-octreotate (DOTA-Tyr3-tate) with 111In, 177Lu and 125I were compared and their metabolism in rats was analyzed. The usefulness of high performance liquid chromatography (HPLC) analysis and instant thin-layer chromatography on silica gel (ITLC-SG) for both radiochemical purity determination and analysis of metabolism in urine was investigated. MATERIALS AND METHODs: For labelling with radiometals, the formation of a complex with the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) functionality of the peptide was employed. Radioiodination was performed by the chloramime-T method. The radiochemical purity of radiolabelled peptides and the analyses of rat urine were determined by HPLC and/or ITLC-SG methods. Male Wistar rats were used in the elimination studies. RESULTS: DOTA-Tyr3-tate was simply radiolabelled with radiometals with high yield and high radiochemical purity. Stopping of the reaction was a critical step for radioiodination, therefore labelling of gluc-Tyr3-tate and DOTA-Tyr3-tate with 125I was not so simple and the reaction product had to be purified by preparative HPLC analysis. Whereas 111In-DOTA-Tyr3-tate and 177Lu-DOTA-Tyr3-tate were eliminated in rat urine in a practically unchanged form, a significant proportion of metabolites was observed with radioiodinated peptides, particularly at longer time intervals. CONCLUSION: Labelling of DOTA-Tyr3-tate with radiometals is simple and the radiochemical purity of prepared compounds is very high, while iodination of the peptides demands purification of the product by preparative HPLC. The analysis of rat urine showed that excretion of radioiodinated peptides included a significant proportion of metabolites.

000      
00000naa 2200000 a 4500
001      
bmc10026704
003      
CZ-PrNML
005      
20111210192433.0
008      
101028s2007 gr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Petřík, Miloš $7 xx0169395
245    10
$a Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate / $c M Petrik, A Laznickova, M Laznicek, MR Zalutsky
314    __
$a Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.
520    9_
$a BACKGROUND: Somatostatin analogues labelled with radiometals or radiohalogens are useful for the imaging and treatment of somatostatin receptor-containing tumours. In this study, the procedures for the radioiodination of glucose-Tyr3-octreotate (gluc-Tyr3-tate) and radiolabelling of DOTA-Tyr3-octreotate (DOTA-Tyr3-tate) with 111In, 177Lu and 125I were compared and their metabolism in rats was analyzed. The usefulness of high performance liquid chromatography (HPLC) analysis and instant thin-layer chromatography on silica gel (ITLC-SG) for both radiochemical purity determination and analysis of metabolism in urine was investigated. MATERIALS AND METHODs: For labelling with radiometals, the formation of a complex with the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) functionality of the peptide was employed. Radioiodination was performed by the chloramime-T method. The radiochemical purity of radiolabelled peptides and the analyses of rat urine were determined by HPLC and/or ITLC-SG methods. Male Wistar rats were used in the elimination studies. RESULTS: DOTA-Tyr3-tate was simply radiolabelled with radiometals with high yield and high radiochemical purity. Stopping of the reaction was a critical step for radioiodination, therefore labelling of gluc-Tyr3-tate and DOTA-Tyr3-tate with 125I was not so simple and the reaction product had to be purified by preparative HPLC analysis. Whereas 111In-DOTA-Tyr3-tate and 177Lu-DOTA-Tyr3-tate were eliminated in rat urine in a practically unchanged form, a significant proportion of metabolites was observed with radioiodinated peptides, particularly at longer time intervals. CONCLUSION: Labelling of DOTA-Tyr3-tate with radiometals is simple and the radiochemical purity of prepared compounds is very high, while iodination of the peptides demands purification of the product by preparative HPLC. The analysis of rat urine showed that excretion of radioiodinated peptides included a significant proportion of metabolites.
650    _2
$a zvířata $7 D000818
650    _2
$a krevní proteiny $x metabolismus $7 D001798
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a glukosa $x analogy a deriváty $x metabolismus $7 D005947
650    _2
$a heterocyklické sloučeniny monocyklické $x chemie $x metabolismus $7 D006573
650    _2
$a radioizotopy india $x chemie $7 D007205
650    _2
$a radioizotopy jodu $x chemie $7 D007457
650    _2
$a izotopové značení $7 D007553
650    _2
$a lutecium $x chemie $7 D008187
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a cyklické peptidy $x chemie $x metabolismus $7 D010456
650    _2
$a vazba proteinů $7 D011485
650    _2
$a radionuklidy $x chemie $7 D011868
650    _2
$a radiofarmaka $x chemická syntéza $x metabolismus $7 D019275
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a financování organizované $7 D005381
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Lázníčková, Alice, $d 1948- $7 nlk19990073515
700    1_
$a Lázníček, Milan, $d 1947- $7 nlk19990073514
700    1_
$a Zalutsky, Michael R
773    0_
$w MED00000478 $t Anticancer research $g Roč. 27, č. 6B (2007), s. 3941-3946 $x 0250-7005
910    __
$a ABA008 $b x $y 7
990    __
$a 20101028150601 $b ABA008
991    __
$a 20101029152815 $b ABA008
999    __
$a ok $b bmc $g 801811 $s 666567
BAS    __
$a 3
BMC    __
$a 2007 $b 27 $c 6B $d 3941-3946 $i 0250-7005 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a 2010-B3/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...